|
|
|
MedChem 2004 - Lead Profiling: Myth or Reality? |
|
| 08:00 | Registration |
|
| 08:50 | Introduction |
|
|
| 09:00 | Synthesis and Pharmacological Characterization of Novel Epothilone Derivatives. |
Dr Rainer METTERNICH
(CAPROTEC BIOANALYTICS, Basel, Switzerland) - Arrival 25th 15.20 Bxl airport / Dinner OK Abstract + CV / PP Present OK / |
| 09:50 | Beyond in vitro Activity: Multi-Dimensional Evaluation in the Identification of Quality Lead Series. |
Dr Simona CECCARELLI
(F. HOFFMANN-LA ROCHE, BASEL, Switzerland) - Arrival 25th 13.30 Brx airport / Dinner OK CV OK / Abstract OK /PP Present OK/ |
|
| 10:40 | Coffee break & poster session |
|
| 11:10 | Discovery of UCB 44212: A New Pyrrolidone Derivative With Potent Antiepileptic Properties And High Tolerability in Rodent Models of Epilepsy. |
Dr Philippe MICHEL
(UCB SA, BRAINE-L'ALLEUD, Belgium) - Oral Com/ |
|
| 11:30 | The Discovery and Selection of TMC114, a Next Generation HIV-Protease Inhibitor. |
Dr Piet WIGERINCK
(TIBOTEC, Mechelen, Belgium) - CV OK / Abstract OK |
|
| 12:20 | Lunch |
|
|
| 14:00 | Recent Advances in Computer-Aided Drug Design. |
Prof. William L. JORGENSEN
(YALE UNIVERSITY, New Haven, United States) - Arrival 24th Ghent / CV OK / Abstract OK / |
| 14:50 |
A View of an in vivo Toxicologist on Early ADME-Tox Profiling.
|
Dr A. LAMPO
(JOHNSON & JOHNSON, BEERSE, Belgium) - Dinner no/ no need for h rsv. / Abstract OK / CV OK / PP Present OK/Arrival |
|
| 15:40 | Coffee break & poster session |
|
| 16:10 | Hit Selection, Prioritisation and Follow-up: Identification of Leads with Minimum Number of Liabilities. |
Dr Berthold HINZEN
(BAYER HEALTHCARE PHARMACEUTICALS, WUPPERTAL, Germany) - Arrival / Dinner not sure Oral Com/CV OK/Dinner NO |
|
| 16:30 | Design of Selective Kinase Inhibitors: Facts or Fantasy? |
Dr Gerhard MÜLLER
(PROTEROS FRAGMENTS, Munich, Germany) - Arrival 25/11 12:25 CV OK/Abstract OK/Dinner OK |
|
| 17:20 | Closing remarks |
|
| <Previous page |
